Rational Advisors LLC Boosts Holdings in Colgate-Palmolive Company (CL)
Rational Advisors LLC boosted its position in shares of Colgate-Palmolive Company (NYSE:CL) by 180.9% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 7,608 shares of the company’s stock after buying an additional 4,900 shares during the quarter. Rational Advisors LLC’s holdings in Colgate-Palmolive were worth $564,000 as of its most recent SEC filing.
Other large investors have also recently bought and sold shares of the company. Pinnacle Financial Partners Inc. increased its position in shares of Colgate-Palmolive by 348.4% in the 2nd quarter. Pinnacle Financial Partners Inc. now owns 30,342 shares of the company’s stock valued at $2,249,000 after buying an additional 23,575 shares in the last quarter. Advisors Asset Management Inc. increased its holdings in Colgate-Palmolive by 2.6% during the 2nd quarter. Advisors Asset Management Inc. now owns 185,418 shares of the company’s stock worth $13,745,000 after purchasing an additional 4,721 shares in the last quarter. Pitcairn Co. increased its holdings in Colgate-Palmolive by 1.1% during the 2nd quarter. Pitcairn Co. now owns 6,253 shares of the company’s stock worth $464,000 after purchasing an additional 67 shares in the last quarter. Foster Dykema Cabot & Co. Inc. MA increased its holdings in Colgate-Palmolive by 10.6% during the 2nd quarter. Foster Dykema Cabot & Co. Inc. MA now owns 11,984 shares of the company’s stock worth $888,000 after purchasing an additional 1,150 shares in the last quarter. Finally, Wedbush Securities Inc. increased its holdings in Colgate-Palmolive by 7.3% during the 2nd quarter. Wedbush Securities Inc. now owns 21,062 shares of the company’s stock worth $1,561,000 after purchasing an additional 1,431 shares in the last quarter. 73.09% of the stock is currently owned by hedge funds and other institutional investors.
Colgate-Palmolive Company (CL) opened at 75.99 on Monday. Colgate-Palmolive Company has a 52 week low of $63.43 and a 52 week high of $77.27. The company has a market capitalization of $66.94 billion, a PE ratio of 28.24 and a beta of 0.81. The company has a 50-day moving average of $72.45 and a 200-day moving average of $73.19.
Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, July 21st. The company reported $0.72 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.72. Colgate-Palmolive had a net margin of 15.83% and a return on equity of 3,121.95%. The business had revenue of $3.83 billion for the quarter, compared to analysts’ expectations of $3.89 billion. During the same period in the prior year, the company posted $0.70 EPS. The business’s revenue for the quarter was down .5% compared to the same quarter last year. On average, equities research analysts anticipate that Colgate-Palmolive Company will post $2.89 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, November 15th. Stockholders of record on Monday, October 23rd will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.11%. The ex-dividend date of this dividend is Friday, October 20th. Colgate-Palmolive’s payout ratio is 59.48%.
CL has been the subject of a number of research reports. Zacks Investment Research upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 target price for the company in a report on Tuesday, July 4th. SunTrust Banks, Inc. upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and increased their target price for the stock from $65.00 to $85.00 in a report on Wednesday, October 11th. Jefferies Group LLC increased their target price on Colgate-Palmolive from $76.00 to $77.00 and gave the stock a “hold” rating in a report on Thursday, July 6th. Royal Bank Of Canada reiterated a “hold” rating and set a $74.00 target price on shares of Colgate-Palmolive in a report on Friday, June 30th. Finally, Deutsche Bank AG reiterated a “hold” rating and set a $75.00 target price on shares of Colgate-Palmolive in a report on Monday, July 24th. One equities research analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and five have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $76.85.
In other news, insider Patricia Verduin sold 3,833 shares of the stock in a transaction on Tuesday, August 15th. The shares were sold at an average price of $71.45, for a total value of $273,867.85. Following the transaction, the insider now owns 53,173 shares of the company’s stock, valued at approximately $3,799,210.85. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director John T. Cahill sold 8,000 shares of the stock in a transaction on Thursday, July 27th. The stock was sold at an average price of $72.47, for a total transaction of $579,760.00. Following the completion of the transaction, the director now directly owns 31,786 shares in the company, valued at approximately $2,303,531.42. The disclosure for this sale can be found here. Insiders sold a total of 214,136 shares of company stock worth $15,416,385 in the last three months. Insiders own 1.02% of the company’s stock.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with Analyst Ratings Network's FREE daily email newsletter.